Frontiers in Cancer Immunotherapy 2021
Deadline Mar 29 2021 11:59 PM (EDT)
Description

Event Dates: May 12-14, 2021
Deadline to Submit Abstracts: March 29, 2021

This application is for a virtual Poster Presentation. Poster submissions may also be considered for Short Talks. See here for submission guidelines.

In the decade since the approval of the first checkpoint inhibitor, immunotherapy has shifted the paradigm for cancer treatment, delivering effective and durable responses for numerous patients. During that time, combination therapies, adoptive cell therapies, and cancer vaccines have further expanded the impact of immunotherapy.  Nonetheless, challenges remain in understanding why some tumor types are refractive to immunotherapy and how to better predict patient responses to treatment.  This three-day conference will convene experts in immuno-oncology to discuss the latest research in the field. Topics under consideration will include how insights from the immune response to infection can inform our understanding of cancer immunotherapy, the COVID-19/Immuno-oncology interface, advances in multiple myeloma, cytokines, novel checkpoints and more.

To register for this event, please visit the main website at: https://www.nyas.org/immunotherapy2021

Frontiers in Cancer Immunotherapy 2021


Event Dates: May 12-14, 2021
Deadline to Submit Abstracts: March 29, 2021

This application is for a virtual Poster Presentation. Poster submissions may also be considered for Short Talks. See here for submission guidelines.

In the decade since the approval of the first checkpoint inhibitor, immunotherapy has shifted the paradigm for cancer treatment, delivering effective and durable responses for numerous patients. During that time, combination therapies, adoptive cell therapies, and cancer vaccines have further expanded the impact of immunotherapy.  Nonetheless, challenges remain in understanding why some tumor types are refractive to immunotherapy and how to better predict patient responses to treatment.  This three-day conference will convene experts in immuno-oncology to discuss the latest research in the field. Topics under consideration will include how insights from the immune response to infection can inform our understanding of cancer immunotherapy, the COVID-19/Immuno-oncology interface, advances in multiple myeloma, cytokines, novel checkpoints and more.

To register for this event, please visit the main website at: https://www.nyas.org/immunotherapy2021

Deadline
Mar 29 2021 11:59 PM (EDT)